Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort (Q91400248)
Jump to navigation
Jump to search
scientific article published on 04 February 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort |
scientific article published on 04 February 2019 |
Statements
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort (English)
Erminia Massarelli
Neil H Segal
Sai-Hong I Ou
Ani Balmanoukian
Matthew G Fury
Julie R Brahmer
Jared Weiss
Patrick Schöffski
Scott J Antonia
Christophe Massard
Dan P Zandberg
Samir N Khleif
Feng Xiao
Marlon C Rebelatto
Keith E Steele
Paul B Robbins
Natasha Angra
Xuyang Song
Shaad Abdullah